CLINICAL_TRIALS
trial_result
· 2017-02-17
Clinical Trial Update: Alisertib for Acute Myeloid Leukemia [Phase 1]
Summary
Phase 1 trial of alisertib for acute myeloid leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Acute Myelogenous Leukemia | Phase 1 | Status: COMPLETED